KAP1 stabilizes MYCN mRNA and promotes neuroblastoma tumorigenicity by protecting the RNA m6A reader YTHDC1 protein degradation
J Exp Clin Cancer Res. 2024 May 14;43(1):141. doi: 10.1186/s13046-024-03040-9. ABSTRACT BACKGROUND: Neuroblastoma (NB) patients with amplified MYCN often face a grim prognosis and are …